Australia's largest stock trading and investment forum Australia's #1 stock forum

SBB

Click for more information

0.00%

1.2¢ sunbridge group limited

Andrew P, page-22

First 22 Last

Share
Profile

Follow
Ryan1

3,354 Posts.

24

29/04/15

18:59

Post #: 15183462
Share

Originally posted by Nedved ↑

To be honest, it is the lack of volume that is a bit concerning. Complete lack of volume makes you extremely unloved by the market and in the end lacking liquidity and thinly traded. Think TYO, CMC for other Chinese stocks stuck in the same rut.

As brutal as it is, not only does SBB have to prove its profitable business it (and by 'it' I mean Xu) also needs to disprove the doubt. I know this is grossly unfair as most stocks need only do the former to get the market on board. But this is a different kettle of fish with the escrow dumping, no div, big capex, loan guarantees etc etc etc that have been discussed ad nauseaum on here seemingly forever.

Expand

I think most Chinese listed companies struggle with liquidity not just SBB, have a look at TYO, XXL, PEZ, CIK, CMC, RIS, NCO, to name a few

SBB Price at posting: 4.9¢ Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

CUF

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

HotCopper Highlights: Your most watched stocks for Week 46, 2024

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

EEG

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

First 22 Last

Add SBB (ASX) to my watchlist

SPONSORED BY